Anadys Pharmaceuticals, Inc.
Hepatitis drug maker reports loss of $0.50 per share
Published in Lab Business Week, September 19th, 2004
"We are pleased with the progress we made during the second quarter as we continue to advance the clinical development of our lead Hepatitis C and Hepatitis B programs," said Kleanthis G. Xanthopoulos, PhD, Anadys' president and CEO.
"Meanwhile, we continue to harvest additional promising drug candidates utilizing our integrated drug discovery and development platform, while leveraging these capabilities in discovery collaborations with pharmaceutical and biotechnology companies such as Roche and Daiichi.
"We hope to build on...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2004-09-19)
More Articles from Lab Business Week
- Access Pharmaceuticals, Inc.
Pharmaceutical firm reports loss of $0.17 per share - Akorn, Inc.
Pharmaceutical firm reports 25% increase in revenues - Albany Molecular Research, Inc.
Drug discovery firm reports 22.2% decrease in revenues - Alkermes, Inc.
Pharmaceutical firm reports loss of $0.40 per share - America Oriental Bioengineering
Chinese biotech firm reports 23% revenue increase - Antares Pharma, Inc.
Pharmaceutical firm reports 24% decrease in revenue - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
